Naratriptan Tablet
Product Images NDC 23155-055

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Naratriptan (NDC 23155-055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4e5d65f9 Edda 4b3c 90d2 Ea61733faaf7 01

Chemical structure diagram of naratriptan hydrochloride, the active ingredient shown as a molecular formula with labeled atoms and bonds.*

FDA Label Image

4e5d65f9 Edda 4b3c 90d2 Ea61733faaf7 02

A line graph depicting the estimated probability of response over time in minutes from the initial dose for naratriptan tablets at 1 mg and 2.5 mg compared to placebo. The vertical axis shows the estimated probability of response in percentage, and the horizontal axis shows time in minutes up to 240 minutes. Data points indicate higher response rates for naratriptan 2.5 mg, followed by 1 mg, and the lowest for placebo throughout the time course.*

FDA Label Image

4e5d65f9 Edda 4b3c 90d2 Ea61733faaf7 03

A line graph showing the estimated probability of remediation or rescue over time in hours from the initial dose for naratriptan tablets at USP 1 mg and 2.5 mg doses compared to placebo. The graph compares three groups: placebo, 1 mg dose, and 2.5 mg dose, illustrating their response rates over a 24-hour period.*

FDA Label Image

4e5d65f9 Edda 4b3c 90d2 Ea61733faaf7 04

FDA Label Image

4e5d65f9 Edda 4b3c 90d2 Ea61733faaf7 05

FDA Label Image

4e5d65f9 Edda 4b3c 90d2 Ea61733faaf7 06

Packaging label for Naratriptan Tablets, USP 1 mg oral tablets by Avet Pharmaceuticals Inc. The carton includes 9 unit-of-use tablets and instructs pharmacists to dispense the patient information leaflet with the drug product. The label shows storage instructions, a barcode, and manufacturer details for USV Private Limited in India. It includes illustrations on how to tear the blister and peel the backing to access tablets.*

FDA Label Image

4e5d65f9 Edda 4b3c 90d2 Ea61733faaf7 07

Packaging label sheet containing multiple panels for Naratriptan Tablet, USP 1 mg oral tablets. Each panel includes product name, strength (1 mg), barcodes, manufacturer Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., and placeholders for lot number and expiration date. The layout is designed for cutting into individual labels.*

FDA Label Image

4e5d65f9 Edda 4b3c 90d2 Ea61733faaf7 08

Packaging label for Naratriptan Tablets, USP 2.5 mg by Avet Pharmaceuticals Inc. The label includes instructions for pharmacists to dispense the patient information leaflet, indicates 9 unit-of-use tablets per package, and provides storage information. The label shows a blister pack format with tear and peel instructions, a barcode, manufacturer details (USV Private Limited, India), and space for a pharmacy label.*

FDA Label Image

4e5d65f9 Edda 4b3c 90d2 Ea61733faaf7 09

Carton label for naratriptan tablets, USP, with strength 2.5 mg, manufactured for Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. The label includes multiple panels showing barcodes, NDC 23155-055-18, and spaces for lot number and expiration date. The dosage form is oral tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.